Withings announces Move and Move ECG fitness and health tracking devices

Withings announces Move and Move ECG fitness and health tracking devices

In addition to today’s announcement of BPM Core, Withings has also released two new fitness and health trackers, Move and Move ECG. Withings Move ($70) is a fashionably-designed analog watch that follows in the trend first started by the company’s 2014 Activité, incorporating fitness tracking into a more typical watch design. Move brings the fitness features of Activité and Steel HR Sport into a more affordable device, with built-in advanced activity and sleep racking capabilities along with more design options to fit users’ own personal style, with a range of case, wristband, dial, handle, watch face colors, and material combinations. The traditional timepiece design features three dials, two of which display the time and one that visualizes the user’s activity progression based on goals set in the Withings Health mate app. Users can also connect to a wide range of more than 100 third-party fitness apps such as Apple’s HealthKit, Google Fit, or MyFitnessPal for automatically tracking normal daily activities such as walking, running, swimming, and cycling as well as starting on-demand workouts for specific sessions. Sleep monitoring features also allow users to get an analysis of their sleep patterns, including length, depth, and quality of sleep, along with a smart wakeup feature that uses vibration alarms to wake users at optimal times during the sleep cycle. Move ECG ($130) includes all of the activity and sleep tracking features of Move, while also adding a medical-grade electrocardiogram feature, allowing users to easily monitor their cardiovascular health at any time and detect heart conditions such as atrial fibrillation (AFib). Move is available for pre-order now from Withings’ web site in five different color options, with the company promising to expand the collection regularly with new design schemes. Move ECG is currently under review for FDA and CE clearance and is expected to be available in Q2 2019 in both the U.S. and Europe.